• Home
  • Our Focus
  • Science
  • Pipeline
  • Team
  • News
  • Contact
  • Menu Menu

Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders

February 24, 2026/in News
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2026-02-24 08:00:112026-04-27 18:03:14Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders

© 2026 Slate Medicines. All Rights Reserved. | Terms of Use | Privacy Notice

Scroll to top Scroll to top Scroll to top